Cancer care has been improved by the discovery of precision medicine - using molecular and genetic tests to determine the best treatments for an individual patient's tumor. We are doing this study to better understand how precision medicine is delivered. We also want to learn the barriers to precision medicine, particularly for underserved populations.
Thank you for your interest, but this study is not currently enrolling.
North Carolina (Statewide)
Jake Stein
Health Behavior
Clinical or Medical
Observational
Cancer (Lung)
Minority Health
20-3310
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
